Cargando…
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus
OBJECTIVE: Patient-reported outcomes (PROs) are important measures of the quality of life (QOL) and symptoms in patients with hepatitis C virus (HCV). We evaluated the PROs at the beginning of direct-acting antiviral (DAA) treatment and three years later. A low QOL in patients with chronic liver dis...
Autores principales: | Ichikawa, Tatsuki, Miyaaki, Hisamitsu, Miuma, Satoshi, Motoyoshi, Yasuhide, Yamashima, Mio, Yamamichi, Shinobu, Koike, Makiko, Nakano, Yusuke, Honda, Tetsurou, Yajima, Hiroyuki, Uehara, Ryouhei, Miyazaki, Osamu, Kuribayashi, Yasutaka, Kira, Keiji, Taura, Naota, Nakao, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691030/ https://www.ncbi.nlm.nih.gov/pubmed/33132304 http://dx.doi.org/10.2169/internalmedicine.5102-20 |
Ejemplares similares
-
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease
por: Ichikawa, Tatsuki, et al.
Publicado: (2021) -
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide
por: Okamura, Takuma, et al.
Publicado: (2022) -
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection
por: Ichikawa, Tatsuki, et al.
Publicado: (2019) -
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
por: Senoo, Takemasa, et al.
Publicado: (2018) -
Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)